Company Evogene Ltd Other OTC

Equities

IL0011050551

Biotechnology & Medical Research

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Share class

Shareholders

Company contact information

Sector

Sales per Business

Sales per region

Sector Other Biotechnology & Medical Research

Inactive Instrument

End-of-day quote Other OTC Other stock markets
- ^USD	-

05-23	Earnings Flash (EVGN) EVOGENE Posts Q1 Revenue $4.2M, vs. Street Est of $3.5M	MT
05-23	Evogene Ltd. Provides Revenue Guidance for the Year 2024	CI

Evogene Ltd is an Israel-based company, engaged in leveraging computational biology to design products for life-science-based industries including human health, agriculture, and industrial applications. Leveraging Big Data and Artificial Intelligence while incorporating a deep understanding of biology, Evogene established its technology, the Computational Predictive Biology (CPB) platform, to computationally design microbes, small molecules and genes as the core components for life-science products. Evogene holds a number of subsidiaries utilizing the CPB platform, for the development of human microbiome-based therapeutics, medical cannabis, ag-biologicals, ag-chemicals, seed traits and ag-solutions for castor oil production.

USD in Million	2022	Weight	2023	Weight	Delta
Agriculture 67.2 %	1	52.3 %	4	67.2 %	+332.76%
Industrial Applications 19.1 %	0	4.3 %	1	19.1 %	+1,393.06%
Human Health 8.6 %	1	30.6 %	0	8.6 %	-5.07%
Unallocated 5.1 %	0	12.8 %	0	5.1 %	+34.11%

USD in Million	2022	Weight	2023	Weight	Delta
United States 65.0 %	1	51.0 %	4	65.0 %	+329.15%
Others 19.0 %	0	4.0 %	1	19.0 %	+1,499.40%
Israel 16.0 %	1	45.0 %	1	16.0 %	+19.72%

Managers	Title	Age	Since
Ofer Haviv CEO	Chief Executive Officer	58	31/12/01
Yaron Eldad DFI	Director of Finance/CFO	57	31/03/22
Mark Kapel CTO	Chief Tech/Sci/R&D Officer	48	31/12/04
Eyal Ronen PRN	Corporate Officer/Principal	-	31/05/22
Sassi Masliah PRN	Corporate Officer/Principal	-	31/12/10
Liat Foigel Wejgman HRO	Human Resources Officer	-	31/12/14
Nir Arbel PRN	Corporate Officer/Principal	-	31/07/21
Yisrael Gewirtz AUD	Comptroller/Controller/Auditor	47	-

Members of the board	Title	Age	Since
Dan Falk BRD	Director/Board Member	79	16/11/21
Sarit Firon CHM	Chairman	58	10/08/16
Leon Recanati BRD	Director/Board Member	76	30/04/05
Ofer Haviv CEO	Chief Executive Officer	58	31/12/01
Oded Shoseyov BRD	Director/Board Member	67	31/10/18
Nir Nimrodi BRD	Director/Board Member	55	31/08/22
Adrian Percy BRD	Director/Board Member	59	03/02/19

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	50,584,888	49,746,029 ( 98.34 %)	0	98.34 %

Name	Equities	%	Valuation
SilverArc Capital Management LLC 6.100 %	3,085,503	6.100 %	2 M $
Leon Recanati 1.658 %	838,859	1.658 %	625 093 $
Morgan Stanley Capital Services LLC 0.5615 %	284,048	0.5615 %	211 664 $
KSM Mutual Funds Ltd. 0.5560 %	281,265	0.5560 %	209 590 $
Migdal Mutual Funds Ltd. 0.2871 %	145,251	0.2871 %	108 237 $
P&S Vermögensberatungs AG Performance & Sicherheit 0.1977 %	100,000	0.1977 %	74 517 $
BNP Paribas Arbitrage SA 0.1807 %	91,400	0.1807 %	68 109 $
LPL Financial LLC 0.1321 %	66,835	0.1321 %	49 803 $
UBS Financial Services, Inc. 0.1235 %	62,495	0.1235 %	46 569 $
Citadel Securities GP LLC 0.1184 %	59,911	0.1184 %	44 644 $

Evogene Ltd.

13 Gad Feinstein Street Park Rehovot

7638517, Rehovot

http://www.evogene.com

Healthcare

Pharmaceuticals & Medical Research

Biotechnology & Medical Research

Biotechnology & Medical Research

Other Biotechnology & Medical Research

	1st Jan change	Capi.
MODERNA, INC.	+38.36%	52.73B
LONZA GROUP AG	+38.59%	39B
IQVIA HOLDINGS INC.	-8.63%	38.52B
ALNYLAM PHARMACEUTICALS, INC.	+25.46%	30.38B
CELLTRION, INC.	-11.17%	26.39B
ICON PUBLIC LIMITED COMPANY	+11.44%	26.08B
UNITED THERAPEUTICS CORPORATION	+45.09%	14.15B
MEDPACE HOLDINGS, INC.	+32.93%	12.6B
BIO-TECHNE CORPORATION	-5.30%	11.51B

Other Biotechnology & Medical Research